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Abstract: We identify locally D-optimal crossover designs for generalized linear models. We use
generalized estimating equations to estimate the model parameters along with their variances.
To capture the dependency among the observations coming from the same subject, we propose
six different correlation structures. We identify the optimal allocations of units for different
sequences of treatments. For two-treatment crossover designs, we show via simulations that the
optimal allocations are reasonably robust to different choices of the correlation structures. We
discuss a real example of multiple treatment crossover experiments using Latin square designs.
Using a simulation study, we show that a two-stage design with our locally D-optimal design at
the second stage is more efficient than the uniform design, especially when the responses from
the same subject are correlated.
Key words and phrases: Approximate Designs, D-Optimality, Compound Symmetric Correla-
tion, AR(1) Correlation Structure, Generalized Estimating Equations, Two-Stage Design.
1 Introduction
Pharmaceutical companies frequently conduct clinical trials where the outcome is either success
or failure of a particular therapy. Crossover designs, also known as repeated measurements
designs or change-over designs, have been used extensively in pharmaceutical research. There
is a rich literature on optimal crossover designs when the response can be adequately modeled
by normal distributions. However, for a binary outcome, where the response needs to be
described using generalized linear models (GLMs), limited results are known. Consequently,
these trials are usually designed using the guidelines of traditional crossover designs obtained
using the theory of linear models. However, these designs can be quite inefficient for GLMs.
Our goal is to bridge this gap in the literature and determine efficient designs specifically
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for crossover experiments with responses under univariate GLMs, including binary, binomial,
Poisson, Gamma, Inverse Gaussian responses, etc.
Among different types of experiments that are available for treatment comparisons with multiple
periods, the crossover designs are among the most important ones. In these experiments, every
subject is exposed to a sequence of treatments over different time periods, i.e., subjects crossover
from one treatment to another. One of the most important aspects of crossover designs is that
we can get the same number of observations as other designs but with less number of subjects.
This is an important consideration since human participants are often scarce in clinical trials.
The order in which treatments are applied to subjects is known as a sequence and the time
at which these sequences are applied is known as a period. In most of the cases, the main
aim of such experiments is to compare t treatments over p periods. In each period, each
subject receives a treatment, and the corresponding response is recorded. In different periods,
a subject may receive different treatments, but treatment may also be repeated on the same
subject. Naturally, crossover designs also provide within-subject information about treatment
differences.
Most of the research in the crossover design literature dealt with continuous response variables
(see, for example, Kershner and Federer (1981), Laska and Meisner (1985), Matthews (1987),
Carriere and Huang (2000), and the references therein). The problem of determining optimal
crossover designs for continuous responses has been studied extensively (see, for example, Bose
and Dey (2009), for a review of results). For examples of practical cases where the responses
are discrete in nature, such as binary responses, one may refer to Jones and Kenward (2014)
and Senn (2003).
Among many fixed effects models proposed in the literature, the following linear model is used
extensively to formulate crossover designs.
Yij = λ+ βi + αj + τd(i,j) + ρd(i−1,j) + ij , (1)
where Yij is the observation from the jth subject in the ith time period, with i = 1, . . . , p and
j = 1, . . . , n. Here d(i, j) stands for the treatment assignment to the jth subject at time period
i and λ, βi, αj , τd(i,j), ρd(i−1,j) are the corresponding overall mean, the ith period effect, the
jth subject effect, the direct treatment effect and the carryover treatment effect respectively.
Here ij ’s are the uncorrelated error terms which follow a normal distribution with zero mean
and constant variance. Model (1) is sometimes referred to as the traditional model due to its
extensive use in the literature.
As all the effects are fixed, for the linear model (1), the Fisher information matrix is independent
of model parameters. Various optimality criteria such as A-, D-, E-optimality depend on this
information matrix (see, for example, Pukelsheim (1993)). Numerous results corresponding to
the optimality of crossover designs for linear models are available in the literature. Hedayat
and Afsarinejad (1978), Cheng and Wu (1980) and Kunert (1984b) studied the optimality of
balanced, uniform designs. Cheng and Wu (1980) formulated theorems for optimality of strongly
balanced design. Kunert (1983) produced results for optimality of designs which are neither
balanced nor strongly balanced. Dey et al. (1983) were among the first ones to provide results
for optimality of designs when p ≤ t. Considering arbitrary p and t with both p ≤ t and p ≥ t,
Kushner (1997b) obtained conditions for universal optimality through approximate theory. Such
results cannot be readily extended for binary responses since the Fisher information matrix for
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GLMs depends on the model parameters (McCullagh and Nelder (1989), Stufken and Yang
(2012)). In this paper, we focus on local optimality to circumvent this problem (Khuri et al.
(2006)).
This paper is organized as follows. We describe a preliminary setup of a model for crossover de-
signs for GLMs in Section 2.1 and then discuss generalized estimating equations in Section 2.2.
We propose different correlation structures in Section 2.3 and formulate locally optimal crossover
designs along with an algorithm for obtaining such designs, in Section 2.4. In Sections 3 we
provide examples of optimal design for two-treatment crossover trials. We calculate optimal
designs for examples with binary response in Section 3.1 and for example with Poisson response
in Section 3.2. In Section 4.1, we provide examples of optimal designs for multi-treatment
crossover trials, where we use Latin square design. Sensitivity study and Relative D-efficiency
are presented in Section 4.2. Simulation studies are presented in Section 4.3. The paper con-
cludes with comments in Section 5. Some technical details and additional results are presented
in Appendix and Supplementary Materials.
2 Crossover Designs for GLM
Although there is a rich literature on optimal crossover designs for linear models, the results on
crossover designs under generalized linear models (GLMs) is meagre. Before identifying optimal
crossover design we first formally introduce the GLM and the associated optimal crossover
designs.
2.1 Preliminary Setup
We consider a crossover trial with t treatments, n subjects, and p periods. The responses
obtained from these n subjects are denoted as Y1, . . . , Yn, where the response from the jth
subject is Yj = (Y1j , . . . , Ypj)
′. As discussed above we use a generalized linear model (GLM) to
describe the marginal distribution of Yij as in Liang and Zeger (1986). Let µij denote the mean
of a binary response Yij . To fix ideas, first we consider the logistic regression, which models the
marginal mean µij for crossover trial as
logit(µij) = log
(
µij
1− µij
)
= ηij = λ+ βi + τd(i,j) + ρd(i−1,j), (2)
where i = 1, . . . , p; j = 1, . . . , n; λ is the overall mean, βi represents the effect of the ith period,
τs is the direct effect due to treatment s and ρs is the carryover effect due to treatment s, where
s = 1, . . . , t.
Remark 1 Unlike model (1), model (2) does not contain a subject effect term αj. Note that the
response here is described by a GLM, where the Fisher information matrix depends on model
parameters. In this paper, we consider the local optimality approach of Chernoff (1953), in
which the parameters are replaced by assumed values. In the linear model, the subject effect
can be estimated from the data, but for our local optimality approach for the GLM, an educated
guess for the subject effect is needed. It would be reasonable to guess the fixed treatment effects
from prior knowledge, while from a design point of view the subject effect if included, have to
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be treated as random. Instead of incorporating a random effects term, in this paper, the mean
response is modeled through the logit link function in equation (2) with an extra assumption that
the responses from a particular subject are mutually correlated, while the responses from different
subjects are uncorrelated. In the case of generalized linear models, only the mean response is
modeled through the link function, and hence we are free to choose a variance-covariance matrix
as long as that is positive definite. So, in this paper, we use this opportunity of choosing the
covariance matrix and capture the subject effect by putting different meaningful structures on
this matrix and studying the robustness of the design. In this way, we can exclude a random
subject effect from the model and calculate optimal designs more easily.
As the main interest is in estimating the treatment effects and variance of its estimator, carry-
over effects are treated as nuisance parameters. To ensure estimability of the model parameters,
we set the baseline constraints as β1 = τ1 = ρ1 = 0. Consider β = (β2, . . . , βp)
′ , τ = (τ2, . . . , τt)′
and ρ = (ρ2, . . . , ρt)
′, which define the parameter vector θ = (λ, β, τ, ρ)′. Then the linear pre-
dictor corresponding to the jth subject, ηj = (η1j , . . . , ηpj)
′ can be written as
ηj = Xjθ.
The corresponding design matrixXj can be written asXj = [1p, Pj , Tj , Fj ], where Pj is p×(p−1)
such that Pj = [0(p−1)1, Ip−1]′; where Tj is a p×(t−1) matrix with its (i, s)th entry equal to 1 if
subject j receives the direct effect of the treatment s in the ith period and zero otherwise; where
Fj is a p × (t − 1) matrix with its (i, s)th entry equal to 1 if subject j receives the carryover
effect of the treatment s in the ith period and zero otherwise, where columns of Tj and Fj are
indexed by 2, . . . , t.
If the number of subjects is fixed to n and the number of periods is p, then we determine the
proportion of subjects assigned to a particular treatment sequence. As the number of periods
is fixed to p, each treatment sequence will be of length p and a typical sequence can be written
as ω = (t1, . . . , tp)
′ where ti ∈ {1, . . . , t}. Now, let Ω be the set of all such sequences and nω
denote the number of subjects assigned to sequence ω. Then, the total number of subjects n
can be written as n = Σω∈Ωnω, nω ≥ 0. A crossover design ζ in approximate theory is specified
by the set {pω, ω ∈ Ω}, where pω = nω/n is the proportion of subjects assigned to treatment
sequence ω. Such a crossover design ζ can be denoted as follows:
ζ =
{
ω1 ω2 . . . ωk
pω1 pω2 . . . pωk
}
where k is the number of treatment sequences involved, such that
∑k
i=1 pωi = 1, for i = 1, . . . , k.
From the definitions of matrices Tj and Fj it can be noted that they depend only on the
treatments sequence ω that subject j receives. So it can be inferred that Tj = Tω and Fj = Fω.
This implies, Xj = Xω as Pj = [0(p−1)1, Ip−1]′.
2.2 Generalized Estimating Equations
Generalized estimating equations are quasi-likelihood equations which allow us to estimate
quasi-likelihood estimators. In this paper, instead of using maximum likelihood estimation
(MLE) or ordinary least squares (OLS) to estimate the parameters we use quasi-likelihood
estimation. Earlier we made one important assumption in crossover trials that observations
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from each subject are mutually correlated while the observations from different subjects are
uncorrelated. This dependency between repeated observations from a subject is modeled using
what is called “working correlation” matrix C. If C is the true correlation matrix of Yj , then
from the definition of covariance we can write
Cov(Yj) = D
1/2
j CD
1/2
j ,
where Dj = diag
(
µ1j(1−µ1j), . . . , µpj(1−µpj)
)
. Let us denote Cov(Yj) by Wj . In Zeger et al.
(1988, equation (3.1)) it has been shown that for repeated measurement model, the generalized
estimating equations (GEE) are defined to be
n∑
j=1
∂µ′j
∂θ
W−1j (Yj − µj) = 0
where µj = (µ1j , . . . , µpj)
′ and the asymptotic variance for the GEE estimator θˆ (see Zeger et
al., 1988, equation (3.2)) is
Var(θˆ) =
 n∑
j=1
∂µ′j
∂θ
W−1j
∂µj
∂θ
−1 (3)
where Wj = Cov(Yj). As mentioned by Singh and Mukhopadhyay (2016) in the paper (Zeger
et al., 1988, equation (3.2)) it has also been shown that if the true correlation structure varies
from “working correlation” structure, then Var(θˆ) is given by the sandwich formula
Var(θˆ) = U−1V U−1,
where the U and V in above equation are as follows:
U =
∑
ωΩ
npω
∂µ′ω
∂θ
W−1ω
∂µω
∂θ
, V =
∑
ωΩ
npω
∂µ′ω
∂θ
W−1ω Cov(Yω)W
−1
ω
∂µω
∂θ
. (4)
So it is expected that the effect of variance misspecification on the locally optimal designs will
be minimal. Table A1 presented in the Appendix confirms this.
From above equations (3) and (4), it can be seen that if the true correlation of Yj is equal to C,
then Var(θˆ) = U−1.We have considered carryover effects to be nuisance parameters as the main
interest usually lies in estimating the direct treatment effect contrasts. So, instead of working
with the full variance-covariance matrix of parameter estimator θˆ we concentrate only on the
variance of the estimator of treatment effect Var(τˆ) where
Var(τˆ) = HVar(θˆ)H ′, (5)
H is a (t− 1)×m matrix given by [0(t−1)1, 0(t−1)(p−1), It−1, 0(t−1)(t−1)] where m = p+ 2t− 2 is
the total number of parameters in θ and 0(t−1)(p−1) is a (t− 1)× (p− 1) matrix of zeros.
We calculate optimal proportions such that the variances of estimators of treatment effect is
minimized. In this paper we focus on D-optimality and use the determinant of Var(τˆ) as our
objective function. Note that other optimality criteria such as A-,E-optimality can be applied
similarly. Then an optimal design ζ∗ minimizes the determinant of Var(τˆ) in equation (5)
with respect to pω such that
∑
w∈Ω pw = 1. For illustration, we give an explicit expression
of the information matrix and present the associated calculations for a crossover design in the
Supplementary Materials.
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2.3 Proposed Correlation Structures
As mentioned in the above section, to calculate the variance matrix of parameter estimates, a
predefined working correlation structure for the responses is needed. Any correlation structure
can be assumed for the responses, but if the design is not robust, then the optimal proportions
will vary as the correlation structure varies. So, to check the robustness of design and to make
the design more practically acceptable, optimal proportions using different correlation structures
are calculated. For the design in equation (2) with two treatments A and B, six different types
of correlation structures are proposed, and optimal proportions are calculated. Out of these six
correlation structures, the correlation matrices defined by the first three correlation structures
are fixed and do not depend on treatment sequence whereas the correlation matrices of the
fourth, fifth and sixth types depend on treatment sequences and vary along with treatment
sequences.
The first correlation structure is a compound symmetric correlation structure, i.e.,
Corr(1) = (1− ρ)Ip + ρJp,
where Ip is the identity matrix of order p, and Jp is a p× p matrix with all elements unity.
The second correlation structure is the AR(1) correlation structure, i.e.,
Corr(2) =
(
ρ|i−i
′|
)
,
so that the correlation between responses decreases as the time gap between responses increases.
The third correlation structure is as follows:
Corr(3) =

1 ρ 0 . . . 0 0 0
ρ 1 ρ . . . 0 0 0
...
...
...
0 0 0 . . . ρ 1 ρ
0 0 0 . . . 0 ρ 1
 .
For each correlation structure different correlation matrices using different ρ values are consid-
ered.
To understand the other three correlation structures, we denote the correlation coefficient be-
tween the response when a subject receives treatment A first and the response when the same
subject receives treatment B afterwards as ρAB and, ρBA when the subject receives B first
and A afterwards. Note that in general ρAB is not necessarily the same as ρBA. In a similar
manner we define ρAA and ρBB. To define the fourth type of correlation structure we will
use the same structure as Corr(3) but with different values of correlation coefficient for dif-
ferent treatment sequences. For fourth type of correlation we use ρAB = 0.2, ρBA = 0.5 and
ρAA = 0.1, ρBB = 0.3.
To define fifth and sixth type of correlation structures, we use AR(1) correlation structure with
correlation coefficient depending on treatment sequence. For the fifth type, we use the same
values for ρAB and ρBA and for the sixth type of correlation structure we use different values
for ρAB and ρBA. For both fifth and sixth type of correlation structure we keep ρAA = ρBB.
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These values might vary from example to example and would depend on what treatments A
and B are. As the entries of the correlation matrix depend on which treatment the subject
receives in a particular period, these correlation matrices are different for different treatment
sequences. Here, our aim is to see how optimal proportions vary as we vary values of ρAB and
ρBA.
As an illustration, we consider p = 2 with treatment sequences AB,BA. Then the third type
correlation matrices for both treatment sequences AB and BA will have same structure as
Corr(1). The fourth, fifth and sixth type correlation matrices will have same structure as
follows with different ρ values,
Corr(4/5/6)AB =
(
1 ρAB
ρAB 1
)
, Corr(4/5/6)BA =
(
1 ρBA
ρBA 1
)
.
For p = 3 case we consider an example with treatment sequences ABB,BAA. The fourth type
of correlation matrix will have values as mentioned above. The fifth type correlation matrices
for both treatment sequences ABB and BAA will be the same if in treatment sequences, A
and B are interchangeable and ρAB = ρBA along with ρAA = ρBB. The sixth type correlation
matrices for both treatment sequences ABB and BAA will be different as ρAB and ρBA are
different. We get
Corr(4)ABB =
 1 ρAB 0ρAB 1 ρBB
0 ρBB 1
 , Corr(4)BAA =
 1 ρBA 0ρBA 1 ρAA
0 ρAA 1
 ,
and
Corr(5)ABB = Corr(5)BAA =
 1 ρAB ρ2ABρAB 1 ρBB
ρ2AB ρBB 1
 ,
and
Corr(6)ABB =
 1 ρAB ρ2ABρAB 1 ρBB
ρ2AB ρBB 1
 , Corr(6)BAA =
 1 ρBA ρ2BAρBA 1 ρAA
ρ2BA ρAA 1
 .
Same as the above two cases, for p = 4 case we consider an example with treatment sequences
AABB,BBAA. The fourth type of correlation matrix will be as given below. The fifth type
of correlation matrices for both treatment sequences AABB and BBAA will be same because
in treatment sequences A, B are interchangeable and ρAA = ρBB and ρAB = ρBA. Sixth type
of correlation matrices for both treatment sequences ABB and BAA will be different as ρAB
and ρBA are different. We get
Corr(4)AABB =

1 ρAA 0 0
ρAA 1 ρAB 0
0 ρAB 1 ρBB
0 0 ρBB 1
 , Corr(4)BBAA =

1 ρBB 0 0
ρBB 1 ρBA 0
0 ρBA 1 ρAA
0 0 ρAA 1
 ,
and
Corr(5)AABB = Corr(5)BBAA =

1 ρBB ρ
2
BA ρ
3
BA
ρBB 1 ρBA ρ
2
BB
ρ2BA ρBA 1 ρBB
ρ3BA ρ
2
BA ρBB 1
 ,
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and
Corr(6)AABB =

1 ρAA ρ
2
AB ρ
3
AB
ρAA 1 ρAB ρ
2
AB
ρ2AB ρAB 1 ρBB
ρ3AB ρ
2
AB ρBB 1
 , Corr(6)BBAA =

1 ρBB ρ
2
BA ρ
3
BA
ρBB 1 ρBA ρ
2
BA
ρ2BA ρBA 1 ρAA
ρ3BA ρ
2
BA ρAA 1
 .
For p = 4 case, we discuss another interesting example with four treatments A, B, C and D.
The set of treatment sequences for this example is Ω = {ABCD,BDAC, CADB,DCBA}. This
experiment will be discussed in detail later in Section 4. Note that the treatment sequences are
given by a Latin square design and the treatments are interchangeable.
A B C D
B D A C
C A D B
D C B A
For this example above six different types of correlation matrices are considered. The first
three correlation matrices will be the same as above with ρ = 0.3, ρ = 0.2 and ρ = 0.1
respectively. The fourth type correlation structure will be defined in similar manner as discussed
above. The fifth type correlation matrix is defined using AR(1) correlation structure with
ρAB = ρAC = ρAD = ρBA = ρCA = ρDA = 0.4, ρBC = ρBD = ρCB = ρDB = 0.3 and
ρCD = ρDC = 0.2. For fourth type and sixth type of correlation matrix, ρAB = ρAC = ρAD is
taken to be 0.4. In a similar manner ρBA = ρBC = ρBD is taken to be 0.3 and ρCA = ρCB = ρCD
is taken to be 0.2 and ρDA = ρDB = ρDC taken to be 0.1. As the entries of the correlation
matrix depend on which treatment the subject receives in a particular period, these correlation
matrices are different for different treatment sequences and are listed as follows:
Corr(4)ABCD =

1 ρAB 0 0
ρAB 1 ρBC 0
0 ρBC 1 ρCD
0 0 ρCD 1
 , CorrBDAC =

1 ρBD 0 0
ρBD 1 ρDA 0
0 ρDA 1 ρAC
0 0 ρAC 1
 ,
Corr(4)CADB =

1 ρCA 0 0
ρCA 1 ρAD 0
0 ρAD 1 ρDB
0 0 ρDB 1
 , Corr(4)DCBA =

1 ρDC 0 0
ρDC 1 ρCB 0
0 ρCB 1 ρBA
0 0 ρBA 1
 ,
and
Corr(5/6)ABCD =

1 ρAB ρ
2
AC ρ
3
AD
ρAB 1 ρBC ρ
2
BD
ρ2AC ρBC 1 ρCD
ρ3AD ρ
2
BD ρCD 1
 , Corr(5/6)BDAC =

1 ρBD ρ
2
BA ρ
3
BC
ρBD 1 ρDA ρ
2
DC
ρ2BA ρDA 1 ρAC
ρ3BC ρ
2
DC ρAC 1
 ,
Corr(5/6)CADB =

1 ρCA ρ
2
CD ρ
3
CB
ρCA 1 ρAD ρ
2
AB
ρ2CD ρAD 1 ρDB
ρ3CB ρ
2
AB ρDB 1
 , Corr(5/6)DCBA =

1 ρDC ρ
2
DB ρ
3
DA
ρDC 1 ρCB ρ
2
CA
ρ2DB ρCB 1 ρBA
ρ3DA ρ
2
CA ρBA 1
 .
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In the above, we only specified the forms of correlation structures. Note that for this particular
example, the form of Corr(5) is the same as that of Corr(6) since the treatment sequences are
obtained using a Latin square design. In Section 4, we will consider the above six types of cor-
relation structures and calculate the corresponding optimal proportions. We will also perform
a simulation analysis using this example. For simulation analysis, AR(1) correlation structure
will be considered with different ρ values. We have performed robustness in the Appendix 5
and provided explicit expressions on how to obtain objective function in Supplementary Sec-
tion S1.2.
2.4 Algorithm for Locally Optimal Crossover Trials
In this section, we propose an algorithm to find locally optimal designs for crossover trials.
Assumed values of the model parameters are obtained from some prior knowledge or pilot
studies. To identify the locally optimal crossover design, the major challenge is in minimizing
the objective function. The complexity of the objective function increases with the increase of
t, p and k. We use the solnp function in R for numerical optimization.
Algorithm : Pseudo-code for finding locally optimal crossover designs.
Given assumed values of the parameters, construct the design matrix, correlation matrix, and
the parameter vector.
for
Each subject in each period
Calculate the mean of the response
end
for
Each treatment sequence
Calculate the covariance matrix using the correlation matrix
Diagonal entries of covariance matrix are variances of observations
Variance depends on the distribution of the response
Calculate the inverse of covariance matrix
end
for
Each treatment sequence
Calculate the corresponding derivative matrix
9
Using calculated matrices and variables corresponding to each treatment sequence, com-
pute the variance matrix of parameter estimates
Calculate variance matrix of treatment effects. Its determinant is the required objective
function
end
function
Define the objective function along with the constraints, i.e., sum of proportions is equal
to one
end
solnp Using this constraint optimization function calculate optimal proportions
3 Optimal Designs for Two-treatment Crossover Trials
The crossover designs for which we will calculate the optimal proportions are similar to those
discussed by Laska and Meisner (1985) and Carriere and Huang (2000). Optimal proportions are
listed below for p = 2, 3, 4 for binary response and for p = 2 for poisson response under two sets
of parameter estimates. In this section, we consider only two treatments A and B. Considering
our baseline constraint to be τA = ρA = 0 and β1 = 0 we only have p+ 2 parameters in vector
θ. So, when there are only two treatments involved in the crossover trial, the parameter vector
θ is [λ, β2, . . . , βp, τ2, ρ2].
Optimal proportions for different crossover designs are calculated with each of the six different
correlation structures mention above. For each correlation matrix that we consider, an optimal
design ζ∗ is the one minimizing the determinant of Var(τˆ) in equation (5) with respect to pω
such that
∑
w∈Ω pw = 1.
We use different colors to represent different correlation structures. The color scheme that we
use is as follows:
Correlation Structure Color
Corr(1) (1− ρ)Ip + ρJp with ρ = 0.1
Corr(2) ρ|i−i′|, i 6= i′ with ρ = 0.1
Corr(3) with ρ = 0.1
Corr(4) with ρAB = 0.2, ρBA = 0.5
Corr(5) with ρAB = ρBA = 0.4
Corr(6) with ρAB = 0.4, ρBA = 0.3
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3.1 Optimal Designs for Binary Response
In case of binary response we calculate locally optimal designs under model (2) for different
crossover designs.
We first consider the local optimality approach, for p = 2 case. For illustration purpose, we
assume that the parameter values are θ1 = [λ, β2, τB, ρB] = [0.5,−1.0, 4.0, −2.0] which gives us
non-uniform optimal allocations and θ2 = [λ, β2, τB, ρB] = [0.5, 0.06,−0.35, 0.73] which gives
us approximately uniform allocations. Note that we need to know the parameter values before
calculating the optimal proportions. If the initial guess for the model parameters changes,
the obtained optimal proportions will change as well. For different correlation structures, the
optimal designs (proportions) are stated in Table 1. The same information is presented in
Figure 1 and Figure 2 as well.
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Figure 1: Optimal proportions for p = 2 case under θ1.
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Figure 2: Optimal proportions for p = 2 case under θ2.
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Table 1: Optimal proportions for p = 2 case.
Design Points Corr Optimal proportions under θ1 Optimal proportions under θ2
Corr(1) {0.1770, 0.8230} {0.5070, 0.4930}
Corr(2) {0.1770, 0.8230} {0.5070, 0.4930}
{AB,BA} Corr(3) {0.1770, 0.8230} {0.5070, 0.4930}
Corr(4) {0.1770, 0.8230} {0.5070, 0.4930}
Corr(5) {0.1770, 0.8230} {0.5070, 0.4930}
Corr(6) {0.1770, 0.8230} {0.5070, 0.4930}
Corr(1) {0.0908, 0.5207, 0.0315, 0.3570} {0.2633, 0.2425, 0.2722, 0.2220}
Corr(2) {0.0908, 0.5207, 0.0315, 0.3570} {0.2633, 0.2425, 0.2722, 0.2220}
{AB,BA, Corr(3) {0.0908, 0.5207, 0.0315, 0.3570} {0.2633, 0.2425, 0.2722, 0.2220}
AA,BB} Corr(4) {0.0957, 0.4960, 0.0338, 0.3745} {0.2534, 0.2393, 0.2661, 0.2412}
Corr(5) {0.1002, 0.4941, 0.0379, 0.3678} {0.2496, 0.2359, 0.2801, 0.2344}
Corr(6) {0.0972, 0.5050, 0.0367, 0.3611} {0.2502, 0.2400, 0.2808, 0.2290}
It can be seen from the graphs in Figure 1 and Figure 2 that in case of p = 2 the optimal
proportions do not vary when correlation structure changes both under θ2 and θ1. Uniform
designs (same proportions for each sequence) are often used in practice. It is clear that those
uniform designs are sub-optimal under θ1.
For p = 3 case, as before suppose our guess for the parameter values are θ1 = [λ, β2, β3,
τB, ρB] = [0.5,−1.0, 2.0, 4.0,−2.0] which gives us non-uniform optimal allocations and θ2 = [λ
,β2, β3 ,τB, ρB] = [0.5, 0.06,−0.53,−0.35, 0.73] which gives us approximately uniform optimal
allocations. The designs are presented in Table 2, Figure 3 for the first example, and in Table 3,
Figure 4 for the second example. It can be seen that in case of p = 3 also the optimal proportions
do not vary much when correlation structure changes under both θ1 and θ2. Similar to p = 2
case it is clear from above table that uniform designs are sub-optimal for p = 3 case with two-
and four-treatment sequences under θ1.
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Table 2: Optimal proportions for p = 3 case for designs with two treatment sequences.
Design Points Corr Optimal
proportions
under θ1
Optimal
proportions
under θ2
Corr(1) {0.5756, 0.4244} {0.4880, 0.5120}
Corr(2) {0.5761, 0.4239} {0.4887, 0.5113}
{ABB,BAA} Corr(3) {0.5762, 0.4238} {0.4888, 0.5112}
Corr(4) {0.6120, 0.3880} {0.5416, 0.4584}
Corr(5) {0.5921, 0.4079} {0.4917, 0.5083}
Corr(6) {0.5721, 0.4279} {0.4700, 0.5300}
Corr(1) {0.1768, 0.8232} {0.5070, 0.4930}
Corr(2) {0.1766, 0.8234} {0.5072, 0.4928}
{ABA,BAB} Corr(3) {0.1766, 0.8234} {0.5072, 0.4928}
Corr(4) {0.1756, 0.8244} {0.5217, 0.4783}
Corr(5) {0.1714, 0.8286} {0.5088, 0.4912}
Corr(6) {0.1715, 0.8285} {0.5043, 0.4957}
Corr(1) {0.2713, 0.7287} {0.4927, 0.5073}
Corr(2) {0.2738, 0.7262} {0.4926, 0.5074}
{AAB,BBA} Corr(3) {0.2740, 0.7260} {0.4926, 0.5074}
Corr(4) {0.2685, 0.7315} {0.5181, 0.4819}
Corr(5) {0.2771, 0.7229} {0.4911, 0.5089}
Corr(6) {0.2740, 0.7260} {0.4702, 0.5298}
Table 3: Optimal proportions for p = 3 case for designs with four treatment sequences.
Design
Points
Corr Optimal proportions under θ1 Optimal proportions under θ2
Corr(1) {0.1222, 0.5344, 0.0000, 0.3434} {0.4880, 0.5120, 0.0000, 0.0000}
{ABB, Corr(2) {0.1199, 0.5316, 0.0022, 0.3463} {0.4887, 0.5113, 0.0000, 0.0000}
BAA, Corr(3) {0.1197, 0.5312, 0.0025, 0.3466} {0.4888, 0.5112, 0.0000, 0.0000}
AAA, Corr(4) {0.1115, 0.4975, 0.0100, 0.3720} {0.5398, 0.4556, 0.0046, 0.0000}
BBB} Corr(5) {0.1313, 0.5113, 0.0000, 0.3574} {0.4917, 0.5083, 0.0000, 0.0000}
Corr(6) {0.1233, 0.5236, 0.0018, 0.3513} {0.4700, 0.5300, 0.0000, 0.0000}
Corr(1) {0.0413, 0.1130, 0.4384, 0.4073} {0.3544, 0.1646, 0.3908, 0.0902}
{ABB, Corr(2) {0.0316, 0.1196, 0.4373, 0.4115} {0.4266, 0.0957, 0.4777, 0.0000}
AAB, Corr(3) {0.0304, 0.1204, 0.4371, 0.4121} {0.4271, 0.0953, 0.4776, 0.0000}
BAA, Corr(4) {0.0005, 0.1440, 0.4471, 0.4084} {0.1512, 0.3503, 0.1854, 0.3131}
BBA} Corr(5) {0.0811, 0.1033, 0.4297, 0.3858} {0.4420, 0.0747, 0.4833, 0.0000}
Corr(6) {0.0749, 0.1070, 0.4270, 0.3911} {0.4094, 0.0955, 0.4951, 0.0000}
Corr(1) {0.5755, 0.0000, 0.4244, 0.0000} {0.4606, 0.0194, 0.4710, 0.0490}
{ABB, Corr(2) {0.5761, 0.0000, 0.4239, 0.0000} {0.4430, 0.0391, 0.4526, 0.0653}
ABA, Corr(3) {0.5762, 0.0000, 0.4238, 0.0000} {0.4408, 0.0415, 0.4504, 0.0673}
BAA, Corr(4) {0.6120, 0.0000, 0.3880, 0.0000} {0.4634, 0.1036, 0.4152, 0.0178}
BAB} Corr(5) {0.5921, 0.0000, 0.4079, 0.0000} {0.4582, 0.0280, 0.4642, 0.0496}
Corr(6) {0.5721, 0.0000, 0.4279, 0.0000} {0.4420, 0.0142, 0.4787, 0.0651}
Figure 4 shows that, unlike the previous examples, here under θ1 the optimal proportions vary
a little for different correlation structures. Also, as before, not only the uniform design is sub-
optimal here, the first and third designs have optimal allocations very low for some sequences.
Also it can be observed from Figure 4 that under θ2 for different correlation structures some of
the optimal proportions are zero for all the three designs. Hence under θ2 these designs fail to
have uniform allocations.
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Figure 3: Optimal proportions for p = 3 case with two-treatment sequences under θ1 and θ2
respectively.
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Figure 4: Optimal proportions for p = 3 case with four-treatment sequences under θ1 and θ2
respectively.
For p = 4 case, in a similar way, we calculate locally optimal designs with nominal parameter
values as θ1 = [λ, β2, β3, β4, τB, ρB] = [0.5,−1.0, 2.0,−1.5, 4.0,−2.0] which gives us non-
uniform allocations and θ2 = [λ, β2, β3, β4, τB, ρB] = [0.5, 0.06, −0.53, −0.6, −0.35, 0.73]
which gives us approximately uniform allocations. From Table 4 and Figure 5 it is clear that
similar to p = 2 and p = 3 cases the uniform designs are sub-optimal for p = 4 case under θ1.
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Table 4: Optimal proportions for p = 4 case.
Design Points Corr Optimal
proportions
under θ1
Optimal
proportions
under θ2
Corr(1) {0.2723, 0.7277} {0.4953, 0.5047}
Corr(2) {0.2743, 0.7257} {0.4949, 0.5051}
{AABB,BBAA} Corr(3) {0.2744, 0.7256} {0.4949, 0.5051}
Corr(4) {0.2690, 0.7310} {0.5244, 0.4756}
Corr(5) {0.2772, 0.7228} {0.4937, 0.5063}
Corr(6) {0.2745, 0.7255} {0.4700, 0.5300}
Corr(1) {0.6075, 0.3925} {0.4992, 0.5008}
Corr(2) {0.6045, 0.3955} {0.4998, 0.5002}
{ABBA,BAAB} Corr(3) {0.6042, 0.3958} {0.4998, 0.5002}
Corr(4) {0.5815, 0.4185} {0.4927, 0.5073}
Corr(5) {0.6444, 0.3556} {0.5021, 0.4979}
Corr(6) {0.6419, 0.3581} {0.5007, 0.4993}
Corr(1) {0.1763, 0.8237} {0.5071, 0.4929}
Corr(2) {0.1767, 0.8233} {0.5071, 0.4929}
{ABAB,BABA} Corr(3) {0.1767, 0.8233} {0.5071, 0.4929}
Corr(4) {0.1722, 0.8278} {0.5086, 0.4914}
Corr(6) {0.1714, 0.8286} {0.5031, 0.4969}
In most cases we may not have a clear idea about true correlation structure for responses
and hence we choose an working correlation structure. The results in this section show that
no matter what correlation structure we choose or what parameter estimates we choose, the
proposed design gives almost similar optimal proportions in each case, which suggests that
optimal designs are robust.
3.2 Optimal Designs for Poisson Response
In the case of Poisson response we calculate locally optimal design for following example under
the model,
log(µij) = ηij = λ+ βi + τd(i,j) + ρd(i−1,j), (6)
where notations have the same meaning as in equation (2).
We consider an example described in Layard and Arvesen (1978). In a crossover clinical trial to
test a standard anti-nausea treatment (drug A) against a proposed treatment (drug B), twenty
subjects were tested, ten for each order of administration. The response variable is the number
of episodes of nausea suffered by a patient during the first two hours after cancer chemotherapy,
and for a given patient is approximately Poisson distributed. The data are given in Table 5.
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Table 5: Poisson data from anti-nausea experiment.
Subject (A,B) Group (B,A) Group
Drug A Drug B Drug A Drug B
1 1 1 1 0
2 0 0 1 0
3 1 0 2 0
4 1 1 1 0
5 1 1 0 1
6 0 1 1 1
7 2 1 1 0
8 1 0 2 0
9 0 0 3 1
10 1 0 0 0
Total 8 5 12 3
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Figure 5: Optimal proportions for p = 4 case under θ1 and θ2 respectively.
We calculate optimal designs using two values of parameter estimates. θ1 = [0.2, 0.34, −1.60,
−1.65] represents those parameter estimates that give us non-uniform designs and θ2 = [−0.223,
−0.875, 0.405, −0.105] corresponds to parameter estimates guessed from the data presented in
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Table 6 below.
Table 6: Optimal proportions for anti-nausea experiment.
Design Points Correlation Structure Optimal Design: θ1
Corr(1) (1− ρ)Ip + ρJp with ρ = 0.1 {0.3632, 0.6368}
Corr(2) ρ|i−i′|, i 6= i′ with ρ = 0.1 {0.3632, 0.6368}
{AB,BA} Corr(3) with ρ = 0.1 {0.3632, 0.6368}
Corr(4) with ρAB = 0.2, ρBA = 0.5 {0.3632, 0.6368}
Corr(5) with ρAB = ρBA = 0.4 {0.3632, 0.6368}
Corr(6) with ρAB = 0.4, ρBA = 0.3 {0.3632, 0.6368}
Design Points Correlation Structure Optimal Design: θ2
Corr(1) (1− ρ)Ip + ρJp with ρ = 0.1 {0.5505, 0.4495}
Corr(2) ρ|i−i′|, i 6= i′ with ρ = 0.1 {0.5505, 0.4495}
{AB,BA} Corr(3) with ρ = 0.1 {0.5505, 0.4495}
Corr(4) with ρAB = 0.2, ρBA = 0.5 {0.5505, 0.4495}
Corr(5) with ρAB = ρBA = 0.4 {0.5505, 0.4495}
Corr(6) with ρAB = 0.4, ρBA = 0.3 {0.5505, 0.4495}
It can be noted from the above table that when responses are Poisson in nature the optimal
proportions do not vary much when correlation structure changes under both θ1 and θ2. This
suggests us that even when responses are Poisson in nature the proposed design gives almost
similar optimal proportions for different choice of correlation matrices. Hence, obtained optimal
designs are robust.
4 Optimal Design for Multiple-treatment Crossover Trials
So far we have considered crossover designs with two treatments only. In this section, we extend
our study for multiple treatments. This is motivated by a four-period four treatment trial which
was first given in Kenward and Jones (1992) and later discussed as Example 6.1 in their book
(Kenward and Jones, 2014), Design and Analysis for Crossover Trials.
4.1 Latin Square Design and Optimal Proportions
In this example, binary responses for four-period crossover trial were obtained. There were
four treatments and treatment sequences were allocated at random to eighty different subjects
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at four different periods. At the end of each period, efficacy measurement of each subject was
recorded as success or failure, which resulted in joint outcome at the end of the trial as shown
in Table 7. The dataset contains four different treatment sequences which were decided before
the trial Ω = {ABCD, BDAC, CADB, DCBA} along with the joint outcome of four different
periods from the same subject according to a particular treatment sequence. The numbers
below each sequence denote how many subjects received that particular treatment sequence,
and the particular response was recorded.
Table 7: Binary data from a four-period crossover trial.
Joint Outcome Frequency of Outcome
(1=Success, 0=Failure) ABCD BDAC CADB DCBA
(0,0,0,0) 1 0 1 1
(0,0,0,1) 0 1 1 0
(0,0,1,0) 1 1 0 1
(0,0,1,1) 1 0 0 0
(0,1,0,0) 1 1 1 0
(0,1,0,1) 1 1 1 2
(0,1,1,0) 1 1 1 2
(0,1,1,1) 0 1 1 0
(1,0,0,0) 1 0 1 0
(1,0,0,1) 1 1 0 0
(1,0,1,0) 1 0 1 0
(1,0,1,1) 2 0 0 1
(1,1,0,0) 1 1 1 0
(1,1,0,1) 0 2 2 4
(1,1,1,0) 2 3 3 0
(1,1,1,1) 4 9 5 10
We use the correlation matrices defined in Section 2.3 and calculate the optimal proportions.
As mentioned earlier for estimating parameters we have considered the baseline constraints as
β1 = τA = ρA = 0, so that the design matrix has full column rank and all other parameters are
estimable.
Using these baseline constraints and glm function in R we fit the model, which gives us pa-
rameter estimates for the given data. Then we use these parameter estimates to make a guess
for values of unknown parameters. Our nominal guess for the parameter values is θ2 = [0.5,
0.06, −0.53, −0.6, −0.35, 0.025, −0.23, 0.73, 0.23, 0.30]. Now, we follow the same procedure
as mentioned in above pseudo code and calculate the optimal designs for different correlation
structures. We also calculate optimal proportions by considering parameter estimates that gives
non-uniform designs i.e. θ1 = [−2, 0.25, 0, 0.75, 1, 5, −1.5, −3.5, 2.75, 0.75]. As seen from
Table 8, for the Latin square design the optimal proportions that we obtain using using θ1 are
non-uniform and that using θ2 are nearly uniform.
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Table 8: Optimal proportions for different correlation matrices.
Correlation θ1 θ2
Structure ABCD BDAC CADB DCBA ABCD BDAC CADB DCBA
Corr(1) 0.1725 0.2483 0.2223 0.3569 0.2463 0.2493 0.2504 0.2540
Corr(2) 0.1747 0.2490 0.2184 0.3579 0.2461 0.2493 0.2501 0.2546
Corr(3) 0.1714 0.2480 0.2236 0.3570 0.2461 0.2492 0.2507 0.2540
Corr(4) 0.1788 0.2556 0.2163 0.3493 0.2478 0.2634 0.2334 0.2554
Corr(5) 0.1784 0.2465 0.2101 0.3650 0.2480 0.2517 0.2442 0.2561
Corr(6) 0.1752 0.2531 0.2170 0.3547 0.2470 0.2656 0.2320 0.2554
We also calculate optimal design considering all 24 sequences. We consider Corr(2) and calcu-
late optimal proportions for different values of ρ. Please refer the Supplementary Materials for
details. From the tables in the Supplementary Materials it can be noted that corresponding to
θ1 we have non uniform allocations for the Latin Square design, and almost uniform allocation
corresponding to θ2. In case of non-uniform allocations, although nothing is uniform, the op-
timal design corresponding to θ1 has more zeros. Also note that the allocations do not vary a
lot as ρ changes, particularly for the sequences where we have zero allocations.
4.2 Sensitivity Study and Relative D-efficiency
In this section, we study the performance of the proposed locally optimal designs via sensitivity
study in terms of relative D-efficiencies. Let θt be true parameter values and θc be assumed
parameter values. Then we have corresponding objective function for these two choice of pa-
rameter values i.e det(var(τˆt)) and det(var(τˆc)) respectively. Hence the relative loss of efficiency
of choosing θc instead of θt can be formulated as
S(τt, τc) =
det(var(τˆt))
(− 1
k
) − det(var(τˆc))(− 1k )
det(var(τˆt))
(− 1
k
)
,
where k is the dimension of τ . Then the relative D-efficiency of the original design ξ compared
to the optimal design ξ∗ can be computed using the formula:
Eξ =
[
det(var(τˆc))ξ∗
det(var(τˆt))ξ
]− 1
k
.
For the Latin square design example we consider following two cases of assumed values θc
for model parameters. For each case the values of parameters are simulated from a uniform
distribution. The range of uniform distribution is obtained by ±1 and ±2 from true parameter
values θt for each case respectively. Here we consider θt = [0.5, 0.06, −0.53, −0.6, −0.35, 0.025,
−0.23, 0.73, 0.23, 0.30].
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Table 9: Assumed values for model parameters.
Parameters θc Case 1 Case 2
λ U(−0.5, 1.5) U(−1.5, 2.5)
β2 U(−0.04, 0.16) U(−0.14, 0.26)
β3 U(−1.53, 0.47) U(−2.53, 1.47)
β4 U(−1.6, 0.4) U(−2.6, 1.4)
τ2 U(−1.35, 0.65) U(−2.35, 1.65)
τ3 U(−0.075, 0.125) U(−0.175, 0.225)
τ4 U(−1.23, 0.77) U(−2.23, 1.77)
ρ2 U(−0.27, 1.73) U(−1.27, 2.73)
ρ3 U(−0.77, 1.23) U(−1.77, 2.23)
ρ4 U(−0.70, 1.30) U(−1.70, 2.30)
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Figure 6: Performance of the locally optimal designs.
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4.3 Simulation Studies with Two-Stage Designs
As stated earlier the main aim of this paper is to determine optimal and efficient crossover de-
signs for experiments where the generalized linear model adequately describes the process under
study. Crossover trials are repeated measurement designs, where these repeated measurements
on the same subject have great advantages, but there are also many potential disadvantages
associated with it. Nevertheless, the impact of these disadvantages can be minimized or reduced
if we choose a proper design and analysis method.
One of the major disadvantages of repeated measurement designs is that the effect of the treat-
ment depends on the subject itself. Stronger subject effects cause more variation on estimated
treatment effects.
The simulation studies are motivated by the real-life example of Latin square design men-
tioned above. Since all the correlation structures mentioned in Section 2.3 perform similarly
in Table 8, we choose Corr(2) for illustration purpose. Note that in Corr(2), we have AR(1)
structure, where the correlation between two responses decreases as the number of periods be-
tween responses increases, which makes good practical sense. For these simulation studies we
are considering 400 observations and two different types of initial guess for θ values. In Case 1
we will use θ2 = [0.5, 0.06, −0.53, −0.6, −0.35, 0.025, −0.23, 0.73, 0.23, 0.30] which is obtained
from real data. This choice of θ2 gives optimal allocations as (0.2460, 0.2495, 0.2500, 0.2545),
which is approximately uniform. For Case 2 we will use θ1 = [−2, 0.25, 0, 0.75, 1, 5, −1.5,
−3.5, 2.75, 0.75] and this guess of θ1 is such that optimal allocations are non-uniform. For
example for ρ = 0.1 the optimal allocations are (0.172, 0.248, 0.222, 0.358). Optimal allocations
are similar for other values of ρ.
The simulation process used here has two stages. First for a given parameter θ, we define a
design matrix corresponding to each treatment sequence along with correlation matrix.
• First Stage:
1. In this stage, we use rbin function in R to simulate 30% of observations uniformly
over all four treatment sequence. These observations serve as our pilot study. Note
that we use uniform design for pilot study.
2. From these observations obtained in above step we estimate the correlation coefficient
and regression parameters, which are used as the assumed parameter values for the
second stage.
• Second Stage:
1. Based on the assumed parameter values obtained in the first stage and the algorithm
described in Section 2.4, we calculate the optimal allocation for the remaining 70%
of the subjects.
2. Using these optimal allocation we simulate observations for remaining 70% of sub-
jects according to the assumed parameter values.
3. In case of uniform design, we simulate total number of observations uniformly over
all treatment sequence i.e., one-fourth of the total observations correspond to each
of the four treatment sequence.
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During this process we calculate the parameter estimates based on the simulated observations
and calculate the corresponding Mean Square Error (MSE) from the true parameter values
for each simulation. Above simulation procedure is repeated 100 times. Finally we take the
average of those individual MSEs to calculate the overall MSE reported in Table 10. We repeat
the above simulation process for different correlation coefficients and for two different sets of
initial θ’s, θ1 and θ2. It is clear from Table 10 and Figure 10 that if the optimal allocations are
non-uniform, then the proposed optimal design has a significant advantage over the traditional
uniform designs, for all values of the correlation coefficients. It should be noted that those
high values of MSEs for uniform designs are mostly due to a handful of “bad” datasets. In our
experience, the proposed optimal designs never give rise to such data.
Table 10: Simulation results.
Corr Mean Squared Errors
Corr(2) Case 1 Case 2
Uniform Optimal Uniform Optimal
ρ Design Design Design Design
0.1 0.109 0.108 2.834 0.393
0.2 0.103 0.100 2.718 0.659
0.3 0.101 0.140 4.925 0.490
0.4 0.094 0.127 4.896 0.484
0.5 0.100 0.123 2.596 0.428
0.6 0.088 0.109 2.632 0.469
0.7 0.086 0.095 5.110 0.458
0.8 0.066 0.077 2.705 0.586
0.9 0.050 0.051 2.761 0.559
5 Discussion
In practice, it is customary to use uniform designs where the same number of subjects are
assigned to each treatment sequence. In the case of linear models, such uniform designs are
optimal. However, optimal proportions obtained under generalized linear models are not uni-
form. We identified locally optimal designs under different correlation structures. Tables 1 to 4
and graphs in Figures 1 to 5 suggest that the optimal proportions do not vary much from one
correlation structure to another. These results suggest that the identified designs are robust.
Simulation studies and results in Table 10 and Figure 7 suggest that these designs are more
efficient than uniform designs as well.
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Figure 7: Simulation Results: Ratios of MSEs of the Uniform versus Optimal designs, for
different values of ρ, for each of the two cases.
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Appendix
Effect of Misspecification of Working Correlation Structures
The table below lists the locally optimal design when true correlation structure varies from
working correlation structure. In the table first column represents true correlation structure
and the corresponding optimal designs are calculated under θ1 and θ2 for each misspecified
working correlation structure in second column. Also, relative D-efficiency is calculated under
θ1 and θ2 for each design. It is clear from the relative D-efficiency values in the table that the
effect of variance misspecification on the locally optimal design is minimal.
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Table A1: Optimal design after variance misspecification.
True
Correlation
Working
Correlation
Optimal proportions for θ1 Optimal proportions for θ2 Relative D-efficiency
Structure Structure ABCD BDAC CADB DCBA ABCD BDAC CADB DCBA under θ1 under θ2
Corr(2) 0.1723 0.2483 0.2222 0.3572 0.2463 0.2493 0.2504 0.2540 0.9999 0.9999
Corr(3) 0.1726 0.2483 0.2223 0.3568 0.2463 0.2493 0.2504 0.2540 0.9999 0.9999
Corr(1) Corr(4) 0.1723 0.2513 0.2202 0.3562 0.2500 0.2500 0.2500 0.2500 0.9997 0.9988
Corr(5) 0.2447 0.1713 0.2495 0.2223 0.3569 0.2475 0.2557 0.2521 0.9994 0.9995
Corr(6) 0.2500 0.1724 0.2508 0.2197 0.3571 0.2500 0.2500 0.2500 0.9999 0.9984
Corr(1) 0.1745 0.2489 0.2183 0.3583 0.2462 0.2493 0.2500 0.2545 0.9999 0.9999
Corr(3) 0.1744 0.2489 0.2182 0.3585 0.2462 0.2493 0.2500 0.2545 0.9999 0.9999
Corr(2) Corr(4) 0.1745 0.2514 0.2177 0.3564 0.2500 0.2500 0.2500 0.2500 0.9998 0.9987
Corr(5) 0.1740 0.2503 0.2180 0.3577 0.2450 0.2480 0.2530 0.2540 0.9997 0.9997
Corr(6) 0.1744 0.2512 0.2174 0.3570 0.2463 0.2497 0.2505 0.2535 0.9999 0.9985
Corr(1) 0.1714 0.2480 0.2236 0.3570 0.2461 0.2492 0.2507 0.2540 0.9999 0.9999
Corr(2) 0.1711 0.2480 0.2235 0.3574 0.2462 0.2492 0.2506 0.2540 0.9999 0.9999
Corr(3) Corr(4) 0.1713 0.2516 0.2209 0.3562 0.2500 0.2500 0.2500 0.2500 0.9996 0.9987
Corr(5) 0.1700 0.2463 0.2235 0.3572 0.2441 0.2476 0.2561 0.2522 0.9992 0.9995
Corr(6) 0.1713 0.2510 0.2204 0.3573 0.2500 0.2500 0.2500 0.2500 0.9999 0.9984
Corr(1) 0.1783 0.2585 0.2140 0.3492 0.2500 0.2637 0.2347 0.2516 0.9994 0.9987
Corr(2) 0.1784 0.2580 0.2156 0.3480 0.2486 0.2640 0.2344 0.2530 0.9996 0.9987
Corr(4) Corr(3) 0.1782 0.2592 0.2131 0.3495 0.2498 0.2643 0.2342 0.2517 0.9992 0.9986
Corr(5) 0.1778 0.2579 0.2167 0.3476 0.2470 0.2650 0.2343 0.2537 0.9992 0.9993
Corr(6) 0.1790 0.2555 0.2165 0.3490 0.2485 0.2631 0.2337 0.2547 0.9999 0.9999
Corr(1) 0.1774 0.2477 0.2092 0.3657 0.2466 0.2501 0.2486 0.2547 0.9994 0.9999
Corr(2) 0.1776 0.2476 0.2099 0.3649 0.2470 0.2506 0.2470 0.2554 0.9997 0.9999
Corr(5) Corr(3) 0.1770 0.2477 0.2087 0.3666 0.2462 0.2503 0.2485 0.2550 0.9992 0.9999
Corr(4) 0.1776 0.2492 0.2108 0.3624 0.2472 0.2538 0.2450 0.2540 0.9996 0.9994
Corr(6) 0.1774 0.2496 0.2110 0.3620 0.2465 0.2535 0.2456 0.2544 0.9998 0.9991
Corr(1) 0.1748 0.2553 0.2142 0.3557 0.2482 0.2652 0.2332 0.2534 0.9997 0.9985
Corr(2) 0.1748 0.2551 0.2160 0.3541 0.2470 0.2657 0.2329 0.2544 0.9999 0.9985
Corr(6) Corr(3) 0.1748 0.2558 0.2133 0.3561 0.2482 0.2660 0.2325 0.2533 0.9996 0.9984
Corr(4) 0.1754 0.2530 0.2172 0.3544 0.2476 0.2652 0.2324 0.2548 0.9999 0.9999
Corr(5) 0.1741 0.2556 0.2180 0.3523 0.2452 0.2669 0.2339 0.2540 0.9994 0.9991
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S1 Supplementary Material
S1.1 Optimal Design for Latin Square Example with 24 Sequences
In this section we present the optimal designs corresponding to 24 sequences under θ1 and θ2.
S1.2 Explicit Expression of the Objective Function
In this section we workout the explicit expression for objective function and mention all the
required steps.
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S1 Supplementary Material
S1.1 Optimal Design for Latin Square Example with 24 Sequences.
Following tables represent optimal designs for Latin square example with 24 sequences under
θ1 and θ2.
Table S1.1: Optimal design considering 24 sequences under θ1
Treatment Se-
quence
Optimal Designs for θ1
ρ = 0.1 ρ = 0.2 ρ = 0.5 ρ = 0.6 ρ = 0.7 ρ = 0.9
ABCD 0.0094 0.0071 0.0109 0.0119 0.0125 0.0122
ABDC
ACBD 0.0716 0.1037 0.1148 0.1156 0.1153 0.1115
ADBC 0.1096 0.0820 0.0753 0.0795 0.0859 0.1003
ACDB
ADCB
BACD 0.0513 0.0537 0.0459 0.0417 0.0362 0.0250
BADC
CABD 0.1254 0.1162 0.1042 0.1007 0.0972 0.0878
DABC 0.0200 0.0447 0.0469 0.0421 0.0356 0.0194
CADB
DACB 0.0122
BCAD
BDAC 0.1735 0.1993 0.2055 0.2045 0.2031 0.2019
CBAD
DBAC 0.1667 0.1404 0.1374 0.1461 0.1588 0.1924
CDAB 0.1265 0.1426 0.1483 0.1473 0.1448 0.1358
DCAB 0.1114 0.1082 0.1108 0.1107 0.1106 0.1120
BCDA
BDCA 0.0224 0.0003
CBDA
DBCA
CDBA
DCBA
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Table S1.2: Optimal design considering 24 sequences under θ2.
Treatment Se-
quence
Optimal Designs for θ2
ρ = 0.1 ρ = 0.2 ρ = 0.5 ρ = 0.6 ρ = 0.7 ρ = 0.9
ABCD 0.1105 0.1107 0.0875 0.0870 0.0876 0.0846
ABDC 0.0112
ACBD 0.0488 0.0525 0.0615 0.0624 0.0625 0.0522
ADBC 0.0347 0.0329 0.0516 0.0561 0.0618 0.0807
ACDB 0.0402 0.0348 0.0126 0.0128 0.0135 0.0247
ADCB 0.0370 0.0417 0.0645 0.0625 0.0587 0.0383
BACD 0.0052
BADC 0.1125 0.1109 0.0903 0.0855 0.0801 0.0545
CABD 0.0467 0.0419 0.0127 0.0087 0.0054 0.0125
DABC 0.0041 0.0213 0.0192 0.0152
CADB 0.0611 0.0619 0.0729 0.0733 0.0737 0.0674
DACB 0.0136 0.0198 0.0272 0.0537
BCAD 0.0363 0.0371 0.0472 0.0441 0.0392 0.0141
BDAC 0.0034 0.0003 0.0008 0.0027 0.0224
CBAD 0.0004 0.0360 0.0427 0.0503 0.0744
DBAC 0.1034 0.1056 0.0854 0.0859 0.0858 0.0728
CDAB 0.0055
DCAB 0.1157 0.1163 0.0946 0.0915 0.0888 0.0780
BCDA 0.0241 0.0294 0.0361 0.0617
BDCA 0.0882 0.0901 0.0719 0.0728 0.0733 0.0678
CBDA 0.0239 0.0297 0.0369 0.0356 0.0326 0.0166
DBCA 0.0276 0.0201 0.0238 0.0192 0.0153 0.0109
CDBA 0.1100 0.1093 0.0913 0.0907 0.0902 0.0802
DCBA 0.0106
S1.2 Explicit Expression of the Objective Function
We give an example of Latin square design to illustrate how we obtain the objective function.
We use Corr(1) correlation structure with ρ = 0.2.
First we look at the design matrix for each of the subject. Design matrix is obtained by using
expression of Xj mentioned in Section 2.1.
X1 = XABCD =

1 1 0 0 0 1 0 0 0 0 0 0 0
1 0 1 0 0 0 1 0 0 1 0 0 0
1 0 0 1 0 0 0 1 0 0 1 0 0
1 0 0 0 1 0 0 0 1 0 0 1 0
 ,
X2 = XCADB =

1 1 0 0 0 0 1 0 0 0 0 0 0
1 0 1 0 0 0 0 0 1 0 1 0 0
1 0 0 1 0 1 0 0 0 0 0 0 1
1 0 0 0 1 0 0 1 0 1 0 0 0
 ,
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X3 = XBDAC =

1 1 0 0 0 0 0 1 0 0 0 0 0
1 0 1 0 0 1 0 0 0 0 0 1 0
1 0 0 1 0 0 0 0 1 1 0 0 0
1 0 0 0 1 0 1 0 0 0 0 0 1
 ,
X4 = XDCBA =

1 1 0 0 0 0 0 0 1 0 0 0 0
1 0 1 0 0 0 0 1 0 0 0 0 1
1 0 0 1 0 0 1 0 0 0 0 1 0
1 0 0 0 1 1 0 0 0 0 1 0 0
 .
Now, using the above design matrix for each subject and estimates of parameter values, we
consider θˆ = [0.5, 0.06, −0.53, −0.6, −0.35, 0.025, −0.23, 0.73, 0.23]. Then the values of
ηj = Xj θˆ for each subject can be obtained as follows:
η1 = X1θˆ =

0.534
0.278
0.761
−0.070
 , η2 = X2θˆ =

0.185
1.131
0.307
−0.050
 ,
η3 = X3θˆ =

0.557
0.857
−0.220
−0.122
 , η4 = X4θˆ =

0.307
0.950
−0.112
0.658
 .
Hence, using model (2) mentioned in Section 2.1, we can get corresponding µj =
exp{ηj}
1+exp{ηj} ,
they are as follows:
µ1 =
exp{η1}
1 + exp{η1} =

0.6304156
0.5690558
0.6815708
0.4825071
 , µ2 = exp{η2}1 + exp{η2} =

0.5461185
0.7560234
0.5761528
0.4875026
 ,
µ3 =
exp{η3}
1 + exp{η3} =

0.6357581
0.7020335
0.4452208
0.4695378
 , µ4 = exp{η4}1 + exp{η4} =

0.5761528
0.7211152
0.4720292
0.6588110
 .
We are using compound symmetric correlation structure Corr(1) with ρ = 0.2. Hence we have
C(α) = Corr(1) as true correlation matrix.
Correlation matrix C(α) and matrix H can be written down as follows:
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C(α) =

1 0.2 0.2 0.2
0.2 1 0.2 0.2
0.2 0.2 1 0.2
0.2 0.2 0.2 1
 , H =

0 0 0 0 0 1 0 0 0 0 0 0 0
0 0 0 0 0 0 1 0 0 0 0 0 0
0 0 0 0 0 0 0 1 0 0 0 0 0
0 0 0 0 0 0 0 0 1 0 0 0 0
 .
Using the expression for Cov[Yj ] mentioned below we compute covariance matrix for each
subject. We denote this covariance matrix by Wj for each subject j:
Cov[Yj ] = Wj = D
1/2
j Corr1D
1/2
j
where Dj in above equation is diag
(
µ1j(1−µ1j), . . . , µpj(1−µpj)
)
and p is number of periods.
Hence corresponding Dj for Latin square example are as follows:
D1 =

0.23 0 0 0
0 0.24 0 0
0 0 0.22 0
0 0 0 0.25
 , D2 =

0.25 0 0 0
0 0.18 0 0
0 0 0.24 0
0 0 0 0.25
 ,
D3 =

0.23 0 0 0
0 0.21 0 0
0 0 0.25 0
0 0 0 0.25
 , D4 =

0.24 0 0 0
0 0.20 0 0
0 0 0.25 0
0 0 0 0.22
 .
Calculating matrix D
1/2
j and using the above formula for Wj , we have inverse of Wj matrices
as follows:
W−11 =

4.69 −0.65 −0.69 −0.65
−0.65 4.46 −0.68 −0.63
−0.69 −0.68 5.04 −0.67
−0.65 −0.63 −0.67 4.38
 , W−12 =

4.41 −0.73 −0.64 −0.63
−0.73 5.93 −0.74 −0.73
−0.64 −0.74 4.48 −0.63
−0.63 −0.73 −0.63 4.38
 ,
W−13 =

4.72 −0.71 −0.65 −0.65
−0.71 5.23 −0.69 −0.68
−0.65 −0.69 4.43 −0.63
−0.65 −0.68 −0.63 4.39
 , W−14 =

4.48 −0.70 −0.63 −0.67
−0.70 5.44 −0.70 −0.73
−0.63 −0.70 4.39 −0.66
−0.67 −0.73 −0.66 4.87
 .
Note that Dω = Dj and Wω = Wj .
The variance of parameter estimate Var(θˆ) =
[∑
ωΩ npω
∂µ′ω
∂θ W
−1
ω
∂µω
∂θ
]−1
has another compo-
nent which is ∂µω∂θ and the ith row of
∂µω
∂θ is x
′
idi, where xi is the ith row of design matrix Xω
and di corresponds to ith diagonal entry of matrix Dj .
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Hence, ∂µω∂θ matrix for each subject are as follows:
∂µ1
∂θ
=

0.23 0.23 0 0 0 0.23 0 0 0 0 0 0 0
0.24 0 0.24 0 0 0 0.24 0 0 0.24 0 0 0
0.22 0 0 0.22 0 0 0 0.22 0 0 0.22 0 0
0.25 0 0 0 0.25 0 0 0 0.25 0 0 0.25 0
 ,
∂µ2
∂θ
=

0.25 0.25 0 0 0 0 0.25 0 0 0 0 0 0
0.18 0 0.18 0 0 0 0 0 0.18 0 0.18 0 0
0.24 0 0 0.24 0 0.24 0 0 0 0 0 0 0.24
0.25 0 0 0 0.25 0 0 0.25 0 0.25 0 0 0
 ,
∂µ3
∂θ
=

0.23 0.23 0 0 0 0 0 0.23 0 0 0 0 0
0.21 0 0.21 0 0 0.21 0 0 0 0 0 0.21 0
0.25 0 0 0.25 0 0 0 0 0.25 0.25 0 0 0
0.25 0 0 0 0.25 0 0.25 0 0 0 0 0 0.25
 ,
∂µ4
∂θ
=

0.24 0.24 0 0 0 0 0 0 0.24 0 0 0 0
0.20 0 0.20 0 0 0 0 0.20 0 0 0 0 0.20
0.25 0 0 0.25 0 0 0.25 0 0 0 0 0.25 0
0.22 0 0 0 0.22 0.22 0 0 0 0 0.22 0 0
 .
Using above calculated inverse of each Wω matrix, and the corresponding calculated
∂µω
∂θ ma-
trices we can calculate required 13× 13 matrices ∂µ′ω∂θ W−1ω ∂µω∂θ for each ω.
Further, inverse of
[∑
ωΩ npω
∂µ′ω
∂θ W
−1
ω
∂µω
∂θ
]
i.e Var(θˆ) is found numerically and calculate ob-
jective function Var(τˆ) = HVar(θˆ)H ′, where we try to minimize Var(τˆ) w.r.t pω. This values of
pω which minimizes objective function are optimal proportions we are looking for.
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